Third Harmonic Bio Inc.

Company Profile

Third Harmonic Bio Inc. had its IPO on 2022-09-14 under the ticker symbol THRD.

The company operates in the Healthcare sector and Biotechnology industry. Third Harmonic Bio Inc. has a staff strength of 31 employees.

Stock update

Shares of Third Harmonic Bio Inc. opened at $6.31 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $5.95 - $6.51, and closed at $6.17.

This is a -0.96% slip from the previous day's closing price.

A total volume of 738,338 shares were traded at the close of the day’s session.

In the last one week, shares of Third Harmonic Bio Inc. have slipped by -0.16%.

Third Harmonic Bio Inc.'s Key Ratios

Third Harmonic Bio Inc. has a market cap of $249.55 million, indicating a price to book ratio of 2.7866 and a price to sales ratio of 0.

In the last 12-months Third Harmonic Bio Inc.’s revenue was $0 with a gross profit of $0 and an EBITDA of $-37707000. The EBITDA ratio measures Third Harmonic Bio Inc.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Third Harmonic Bio Inc.’s operating margin was 0% while its return on assets stood at -14% with a return of equity of -18.75%.

In Q2, Third Harmonic Bio Inc.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Third Harmonic Bio Inc.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.54 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Third Harmonic Bio Inc.’s profitability.

Third Harmonic Bio Inc. stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -17.7892. Its price to sales ratio in the trailing 12-months stood at 0.

Third Harmonic Bio Inc. stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$285.82 million

Total Liabilities

$4.22 million

Operating Cash Flow

$0

Capital Expenditure

$168000

Dividend Payout Ratio

0%

Third Harmonic Bio Inc. ended 2024 with $285.82 million in total assets and $0 in total liabilities. Its intangible assets were valued at $285.82 million while shareholder equity stood at $278.01 million.

Third Harmonic Bio Inc. ended 2024 with $0 in deferred long-term liabilities, $4.22 million in other current liabilities, 4000.00 in common stock, $-100041000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $278.13 million and cash and short-term investments were $278.13 million. The company’s total short-term debt was $693,000 while long-term debt stood at $0.

Third Harmonic Bio Inc.’s total current assets stands at $280.37 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.34 million and inventory worth $0.

In 2024, Third Harmonic Bio Inc.'s operating cash flow was $0 while its capital expenditure stood at $168000.

Comparatively, Third Harmonic Bio Inc. paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$6.17

52-Week High

$24.595

52-Week Low

$3.75

Analyst Target Price

$5.3

Third Harmonic Bio Inc. stock is currently trading at $6.17 per share. It touched a 52-week high of $24.595 and a 52-week low of $24.595. Analysts tracking the stock have a 12-month average target price of $5.3.

Its 50-day moving average was $6.1 and 200-day moving average was $6.06 The short ratio stood at 4.05 indicating a short percent outstanding of 0%.

Around 1009.8% of the company’s stock are held by insiders while 9016.1% are held by institutions.